AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSO100201100037CNEUMEDICINES INC.
Overview
Award facts
- Net obligations
- $51.00M
- $50,997,157of $216.59M potential value
- Period of performance
- Sep 15, 2011 to Sep 30, 2018
- Ended
- Modifications
- 20
- Latest action Aug 4, 2026
- Contract type
- Definitive contract
- PIID HHSO100201100037C
Description of requirement
ADVANCEMENT OF HEMAMAX TOWARDS BLA SUBMISSION FOR THE MITIGATION OF HSARS UNDER THE FDA ANIMAL RULE
Dates and value
- Award date
- Signed on Sep 15, 2011
- Current value
- $54,163,469Base and exercised options
- Potential value (if all options are exercised)
- $216,588,069
Obligations by fiscal year of action
- FY2026: -$44,403 (de-obligation)
- FY2018: -$79,193 (de-obligation)
- FY2017: $187,711
- FY2016: $5,981,323
- FY2014: $13,999,818
- FY2013: $8,309,760
- FY2012: $8,834,141
- FY2011: $13,808,000
Total across 8 fiscal years: $50,997,157
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 4, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationPASADENA, CA
UEICCJ6LS8WE2A6
CAGE code47KZ7
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyNEUMEDICINES INC.
Business types and certifications
Women-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Administration For Strategic Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Administration For Strategic Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- 075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Pasadena, Los Angeles County, California 91107-7342
- Congressional district (place of performance)
- CA-28As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 20
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Advancement of hemamax towards bla submission for the mitigation of hsars under the fda animal rule
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 15, 2011Base obligation at award: $13,808,000
- Latest action
- Aug 4, 2026 — CloseoutModification P00020; obligation change -$44,403; administrative: no change in scope or value
- Latest substantive action
- Jan 28, 2016 — Supplemental agreement (within scope)Modification 14
- Latest funding action
- Sep 20, 2018 — Funding onlyModification 19; obligation change -$79,193; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action8
- Supplemental agreement (within scope)5
- Funding only3
- Option exercised3
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$44,403
- Latest action: change in base and all options
- -$44,403
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 21
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2010/2013-0140-000
- 075-2014/2015-0140-000
- 075-2017/2018-0140-000
- Object classes
- 25.1: Advisory and assistance services
- 25.5: Research and development contracts